Annual D&A
$2.75 M
+$53.20 K+1.97%
31 December 2023
Summary:
China Pharma Holdings annual depreciation & amortization is currently $2.75 million, with the most recent change of +$53.20 thousand (+1.97%) on 31 December 2023. During the last 3 years, it has risen by +$74.20 thousand (+2.77%). CPHI annual D&A is now -23.48% below its all-time high of $3.60 million, reached on 31 December 2015.CPHI Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$696.90 K
-$42.40 K-5.74%
30 September 2024
Summary:
China Pharma Holdings quarterly depreciation & amortization is currently $696.90 thousand, with the most recent change of -$42.40 thousand (-5.74%) on 30 September 2024. Over the past year, it has increased by +$13.80 thousand (+2.02%). CPHI quarterly D&A is now -28.63% below its all-time high of $976.50 thousand, reached on 30 September 2021.CPHI Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$2.87 M
+$13.80 K+0.48%
30 September 2024
Summary:
China Pharma Holdings TTM depreciation & amortization is currently $2.87 million, with the most recent change of +$13.80 thousand (+0.48%) on 30 September 2024. Over the past year, it has increased by +$168.60 thousand (+6.25%). CPHI TTM D&A is now -20.36% below its all-time high of $3.60 million, reached on 31 December 2015.CPHI TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CPHI Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2.0% | +2.0% | +6.3% |
| 3 y3 years | +2.8% | -28.6% | -6.9% |
| 5 y5 years | -15.5% | +1.6% | -5.2% |
CPHI Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -10.8% | +2.8% | -28.6% | +9.0% | -7.6% | +7.5% |
| 5 y | 5 years | -15.5% | +2.8% | -28.6% | +9.0% | -7.6% | +8.3% |
| alltime | all time | -23.5% | +3991.7% | -28.6% | +4310.8% | -20.4% | >+9999.0% |
China Pharma Holdings Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $696.90 K(-5.7%) | $2.87 M(+0.5%) |
| June 2024 | - | $739.30 K(+0.7%) | $2.85 M(+1.6%) |
| Mar 2024 | - | $733.80 K(+5.5%) | $2.81 M(+2.0%) |
| Dec 2023 | $2.75 M(+2.0%) | $695.80 K(+1.9%) | $2.75 M(+2.1%) |
| Sept 2023 | - | $683.10 K(-1.7%) | $2.70 M(+0.7%) |
| June 2023 | - | $694.80 K(+2.2%) | $2.68 M(+0.4%) |
| Mar 2023 | - | $679.90 K(+6.3%) | $2.67 M(-1.2%) |
| Dec 2022 | $2.70 M(-12.5%) | $639.40 K(-3.7%) | $2.70 M(-2.6%) |
| Sept 2022 | - | $664.30 K(-2.8%) | $2.77 M(-10.1%) |
| June 2022 | - | $683.20 K(-4.3%) | $3.08 M(-0.6%) |
| Mar 2022 | - | $713.60 K(+0.4%) | $3.10 M(+0.4%) |
| Dec 2021 | $3.09 M(+15.2%) | $710.70 K(-27.2%) | $3.09 M(+0.3%) |
| Sept 2021 | - | $976.50 K(+39.4%) | $3.08 M(+10.9%) |
| June 2021 | - | $700.50 K(+0.0%) | $2.78 M(+1.9%) |
| Mar 2021 | - | $700.20 K(-0.1%) | $2.72 M(+1.7%) |
| Dec 2020 | $2.68 M(-8.5%) | $701.10 K(+4.1%) | $2.68 M(+1.3%) |
| Sept 2020 | - | $673.30 K(+3.7%) | $2.65 M(-0.5%) |
| June 2020 | - | $649.10 K(-1.0%) | $2.66 M(-4.7%) |
| Mar 2020 | - | $655.90 K(-1.7%) | $2.79 M(-4.8%) |
| Dec 2019 | $2.93 M(-10.1%) | $667.00 K(-2.8%) | $2.93 M(-3.1%) |
| Sept 2019 | - | $685.90 K(-12.1%) | $3.02 M(-3.2%) |
| June 2019 | - | $780.40 K(-1.9%) | $3.12 M(-2.3%) |
| Mar 2019 | - | $795.50 K(+4.7%) | $3.19 M(-2.0%) |
| Dec 2018 | $3.26 M(-1.0%) | $759.60 K(-3.2%) | $3.26 M(-2.5%) |
| Sept 2018 | - | $784.80 K(-8.0%) | $3.34 M(-1.0%) |
| June 2018 | - | $852.90 K(-1.0%) | $3.38 M(+1.2%) |
| Mar 2018 | - | $861.40 K(+2.1%) | $3.34 M(+1.4%) |
| Dec 2017 | $3.29 M(+6.9%) | $843.50 K(+2.9%) | $3.29 M(+11.8%) |
| Sept 2017 | - | $819.50 K(+0.8%) | $2.94 M(-1.2%) |
| June 2017 | - | $813.00 K(-0.3%) | $2.98 M(-1.9%) |
| Mar 2017 | - | $815.40 K(+64.7%) | $3.04 M(-1.4%) |
| Dec 2016 | $3.08 M(-14.5%) | $495.00 K(-42.1%) | $3.08 M(-9.8%) |
| Sept 2016 | - | $854.80 K(-1.9%) | $3.41 M(-0.9%) |
| June 2016 | - | $871.10 K(+1.6%) | $3.44 M(-1.8%) |
| Mar 2016 | - | $857.20 K(+3.4%) | $3.50 M(-2.6%) |
| Dec 2015 | $3.60 M(+101.5%) | $828.80 K(-6.4%) | $3.60 M(+1.6%) |
| Sept 2015 | - | $885.00 K(-5.2%) | $3.54 M(+15.2%) |
| June 2015 | - | $933.50 K(-1.9%) | $3.07 M(+26.1%) |
| Mar 2015 | - | $951.20 K(+23.3%) | $2.44 M(+36.5%) |
| Dec 2014 | $1.79 M(+10.7%) | $771.60 K(+84.9%) | $1.79 M(+12.5%) |
| Sept 2014 | - | $417.40 K(+40.1%) | $1.59 M(+5.0%) |
| June 2014 | - | $297.90 K(-0.4%) | $1.51 M(-3.2%) |
| Mar 2014 | - | $299.00 K(-47.8%) | $1.56 M(-3.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | $1.61 M(+10.3%) | $573.10 K(+67.5%) | $1.61 M(+14.7%) |
| Sept 2013 | - | $342.20 K(-1.4%) | $1.41 M(-1.8%) |
| June 2013 | - | $347.10 K(-1.0%) | $1.43 M(-1.2%) |
| Mar 2013 | - | $350.50 K(-4.3%) | $1.45 M(-1.0%) |
| Dec 2012 | $1.46 M(+24.5%) | $366.10 K(-0.4%) | $1.46 M(+23.0%) |
| Sept 2012 | - | $367.50 K(+1.0%) | $1.19 M(+17.4%) |
| June 2012 | - | $363.90 K(-0.4%) | $1.01 M(-7.7%) |
| Mar 2012 | - | $365.20 K(+293.1%) | $1.10 M(-6.5%) |
| Dec 2011 | $1.17 M(-22.0%) | $92.90 K(-51.4%) | $1.17 M(-10.7%) |
| Sept 2011 | - | $191.00 K(-57.5%) | $1.32 M(-15.3%) |
| June 2011 | - | $448.90 K(+1.6%) | $1.55 M(+1.8%) |
| Mar 2011 | - | $442.00 K(+89.0%) | $1.53 M(+1.5%) |
| Dec 2010 | $1.51 M(+10.0%) | $233.90 K(-45.5%) | $1.51 M(-9.0%) |
| Sept 2010 | - | $429.50 K(+1.8%) | $1.65 M(+0.1%) |
| June 2010 | - | $421.90 K(+0.5%) | $1.65 M(+7.9%) |
| Mar 2010 | - | $419.90 K(+9.7%) | $1.53 M(+11.8%) |
| Dec 2009 | $1.37 M(+90.3%) | $382.60 K(-10.5%) | $1.37 M(+14.1%) |
| Sept 2009 | - | $427.40 K(+42.1%) | $1.20 M(+26.8%) |
| June 2009 | - | $300.80 K(+16.6%) | $946.20 K(+16.1%) |
| Mar 2009 | - | $258.00 K(+20.6%) | $814.70 K(+13.2%) |
| Dec 2008 | $719.50 K(+70.3%) | $213.90 K(+23.3%) | $719.50 K(+18.7%) |
| Sept 2008 | - | $173.50 K(+2.5%) | $605.90 K(+9.6%) |
| June 2008 | - | $169.30 K(+4.0%) | $553.00 K(+14.0%) |
| Mar 2008 | - | $162.80 K(+62.3%) | $485.20 K(+14.8%) |
| Dec 2007 | $422.40 K(+6.4%) | $100.30 K(-16.8%) | $422.50 K(-2.0%) |
| Sept 2007 | - | $120.60 K(+18.8%) | $431.10 K(+6.3%) |
| June 2007 | - | $101.50 K(+1.4%) | $405.60 K(-1.6%) |
| Mar 2007 | - | $100.10 K(-8.1%) | $412.00 K(+3.8%) |
| Dec 2006 | $397.00 K(+58.7%) | $108.90 K(+14.5%) | $397.00 K(+37.8%) |
| Sept 2006 | - | $95.10 K(-11.9%) | $288.10 K(+6.3%) |
| June 2006 | - | $107.90 K(+26.8%) | $270.90 K(+66.2%) |
| Mar 2006 | - | $85.10 K(+9.2%) | $163.00 K(+109.2%) |
| Dec 2005 | $250.20 K(-50.4%) | - | - |
| Sept 2005 | - | $77.90 K(+393.0%) | $77.90 K(+15.8%) |
| June 2004 | $504.20 K(+649.2%) | - | - |
| June 2003 | $67.30 K(-19.2%) | $15.80 K(-9.2%) | $67.30 K(-4.0%) |
| Mar 2003 | - | $17.40 K(+3.0%) | $70.10 K(-5.3%) |
| Dec 2002 | - | $16.90 K(-1.7%) | $74.00 K(-7.4%) |
| Sept 2002 | - | $17.20 K(-7.5%) | $79.90 K(-4.1%) |
| June 2002 | $83.30 K | $18.60 K(-12.7%) | $83.30 K(+28.7%) |
| Mar 2002 | - | $21.30 K(-6.6%) | $64.70 K(+49.1%) |
| Dec 2001 | - | $22.80 K(+10.7%) | $43.40 K(+110.7%) |
| Sept 2001 | - | $20.60 K | $20.60 K |
FAQ
- What is China Pharma Holdings annual depreciation & amortization?
- What is the all time high annual D&A for China Pharma Holdings?
- What is China Pharma Holdings annual D&A year-on-year change?
- What is China Pharma Holdings quarterly depreciation & amortization?
- What is the all time high quarterly D&A for China Pharma Holdings?
- What is China Pharma Holdings quarterly D&A year-on-year change?
- What is China Pharma Holdings TTM depreciation & amortization?
- What is the all time high TTM D&A for China Pharma Holdings?
- What is China Pharma Holdings TTM D&A year-on-year change?
What is China Pharma Holdings annual depreciation & amortization?
The current annual D&A of CPHI is $2.75 M
What is the all time high annual D&A for China Pharma Holdings?
China Pharma Holdings all-time high annual depreciation & amortization is $3.60 M
What is China Pharma Holdings annual D&A year-on-year change?
Over the past year, CPHI annual depreciation & amortization has changed by +$53.20 K (+1.97%)
What is China Pharma Holdings quarterly depreciation & amortization?
The current quarterly D&A of CPHI is $696.90 K
What is the all time high quarterly D&A for China Pharma Holdings?
China Pharma Holdings all-time high quarterly depreciation & amortization is $976.50 K
What is China Pharma Holdings quarterly D&A year-on-year change?
Over the past year, CPHI quarterly depreciation & amortization has changed by +$13.80 K (+2.02%)
What is China Pharma Holdings TTM depreciation & amortization?
The current TTM D&A of CPHI is $2.87 M
What is the all time high TTM D&A for China Pharma Holdings?
China Pharma Holdings all-time high TTM depreciation & amortization is $3.60 M
What is China Pharma Holdings TTM D&A year-on-year change?
Over the past year, CPHI TTM depreciation & amortization has changed by +$168.60 K (+6.25%)